Fundz

Aerovate Therapeutics, Inc. reported raising $2.5 Million in an initial SEC Form D filing, from an offering of $2.5 Million

PUBLIC · JBIOJan 08, 2020

Amount Raised

$2.5 Million

$2.5 Million sold, per SEC Form D (first sale Jan 8, 2020)

Round Type

Seed

WalthamInformation TechnologyBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Jade Biosciences raised $2.5 Million in a Seed round, dated January 8, 2020. Jade Biosciences is based in Waltham, Massachusetts, United States.

How much did Jade Biosciences raise?
Jade Biosciences raised $2.5 Million in a Seed round on January 8, 2020.
What does Jade Biosciences do?
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases.
Where is Jade Biosciences based and how big is it?
Jade Biosciences is based in Waltham, Massachusetts, United States.
Who are the decision-makers at Jade Biosciences?
Fundz holds 2 contacts at Jade Biosciences, including the SVP, People. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Jade Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Vaccinex raised $7.5M on February 3, 2020.
  • Immuneering raised $20M on January 27, 2020.
  • Damora Therapeutics, Inc. raised $79M on January 16, 2020.
  • Zevra Therapeutics, Inc. raised $3M (Seed) on January 13, 2020.
  • Verastem Oncology raised $4.8M (Seed) on January 7, 2020.
  • Savara Inc raised $27M on January 2, 2020.

Who to call at Jade Biosciences, and when

A new round usually means Jade Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Jade Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Jade Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Jade Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Jade Biosciences

Location

Waltham, Massachusetts, United States

About

Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE-003, an undisclosed antibody discovery program, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Jade Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLori S., SVP, PeopleSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Jade Biosciences's next move

See what Strategic adds

Jade Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.